Cleland Suzanne S MD is categorized under Ear Nose and Throat Doctors in Portland, OR and active since 1999.
Cleland Suzanne S MD was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Suzanne Cleland at the company’s single location by writing to 501 North Graham St # 455, Portland, Oregon OR 97227 or by phoning (503) 408-1323. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cleland Suzanne S MD |
Contact Person: | Suzanne Cleland |
Address: | 501 North Graham St # 455, Portland, Oregon 97227 |
Phone Number: | (503) 408-1323 |
Website Address: | legacyhealth.org |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ear Nose and Throat Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Cleland Suzanne S MD was started in 1999 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Suzanne Cleland for inquiries that concern Cleland Suzanne S MD by calling the company number (503) 408-1323, as your correspondence is most welcome. Additionally, the physical location of the single location of Cleland Suzanne S MD can be found at the coordinates 45.54288,-122.67089 as well as the street address 501 North Graham St # 455 in Portland, Oregon 97227.
For its online presence, you may visit Cleland Suzanne S MD’s website at legacyhealth.org and engage with its social media outlets through on Twitter and on Facebook.